Jext – reimbursement due to recent price changes

Jext – reimbursement due to recent price changes

For August 2020, a concessionary price of £34.30 (per device) was granted for all generic prescriptions for ‘Adrenaline 150micrograms/0.15ml (1 in 1000) solution for injection pre-filled disposable devices’. This concessionary price will only apply to generically written prescriptions submitted for payment for the dispensing month of August. It is important to note that the concessionary price does NOT apply to any equivalent branded prescriptions issued for Jext^® or Emerade^® (note: Emerade^® is currently unavailable as it was subject to a recent recall).

However, prescriptions for Jext 150mcg/0.15ml (1 in 1,000) solution for injection auto-injectors and Jext 300mcg/0.3ml (1 in 1,000) solution for injection auto-injectors will also be reimbursed at the price of £34.30 for August 2020 prescriptions. This is an exception and will help to avoid contractors dispensing these items (as branded prescriptions) at a loss during the month of August and also avoid the need for contractors to obtain replacement generically written prescriptions for accurate reimbursement.